Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.58 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | NQO1 | P15559 | 1/20 | 0.41 |
| ▸ | ACACB | O00763 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27166279 | 0.89 | HRH3 (0.66) | HRH3LTA4HMAOAMAOBMEN1 | |
| SCHEMBL27166299 | 0.88 | HRH3 (0.59) | HRH3LTA4HMAOAMAOBHTT | |
| SCHEMBL27166283 | 0.87 | HRH3 (0.58) | HRH3LTA4HMAOAMAOBHTT | |
| SCHEMBL27166248 | 0.87 | HRH3 (0.58) | HRH3LTA4HMAOAMAOBHTT | |
| SCHEMBL27280958 | 0.83 | HRH3 (0.55) | HRH3LTA4HMAOATDP1MEN1 | |
| SCHEMBL27154978 | 0.82 | LTA4H (0.64) | HRH3LTA4HMAOAMAOBLMNA | |
| SCHEMBL27150044 | 0.82 | LTA4H (0.64) | HRH3LTA4HMAOAMAOBLMNA | |
| SCHEMBL8192012 | 0.82 | LTA4H (0.64) | HRH3LTA4HMAOAMAOBLMNA | |
| SCHEMBL8200343 | 0.82 | LTA4H (0.64) | HRH3LTA4HMAOAMAOBLMNA | |
| SCHEMBL31549544 | 0.82 | HRH3 (0.50) | HRH3LTA4HACACBALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584251-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052549-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052549-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| EP-4335840-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2024-03-13 | — | — | EP | disclosed |